Plexus Ventures is pleased to announce its appointment by US Pharmacia (Warsaw, Poland) to augment the company's internal resources by providing additional business development services.

Michael O'Sullivan, Managing Director of Plexus Ventures, commented: "With 12 seasoned business development professionals in nine cities worldwide, Plexus Ventures is well-positioned to help US Pharmacia, Poland's leading OTC company, to achieve its growth objectives."

About US Pharmacia
US Pharmacia is the leading OTC company in the Polish market and ranks as the 5th largest OTC company in Europe. US Pharmacia markets well-known consumer brands in the analgesic, cough/cold, GI, allergy and vitamin categories.

Plexus Ventures Chairs Japan Business Development Session at BIO 2008

Plexus Ventures, a leading business development consultancy specializing in pharmaceuticals and biotechnology transactions, announced today that Richard A. Brown, General Partner and Head of Tokyo Office will chair a breakout session at the 2008 BIO International Convention. The session is titled "Not Lost in Translation: Successfully Forging Japanese Pharma and Western Biotech Collaborations" and is part of the "Doing Business Globally" track at the conference taking place June 17-20, 2008 in San Diego, CA.

Mr. Brown's workshop includes speakers from both Western and Japanese companies who have entered into such collaborations, who will discuss practical considerations and funding advantages of working with a Japanese partner, the Japanese business model, deal-making strategies and cultural considerations. Through presentations from four speakers, business development executives and others involved in the deal-making process will hear the perspectives of both sides of these East-West collaborations, and how one manages the entire deal process, from relationship-building, negotiating, structuring the deal, and implementing the collaboration.

Confirmed participants for the June 17, 2008 session are: Jeffrey Abbey, Vice President, Business Development, Argos Therapeutics; P?r Gellerfors, Ph.D., Chief Executive Officer, BioArctic Neuroscience AB; Hideki Hayashi, Senior Vice President, Corporate Business Development, Eisai Co., Ltd.; and Tamao Watanabe, Senior Manager of Business Development, Kirin Pharma Company Limited;

Plexus Ventures' Tokyo office assists Japanese companies to establish and grow their presence outside Japan and Western companies who wish to partner their assets with Japanese. Mr. Brown is active in the Japanese business development community, is a member of PharmaDelegates and the Japanese Pharmaceutical Licensing Association, and has been a regular guest lecturer at the Business Development Training Seminars conducted by Yamasaki Pharma Consulting in Tokyo and Osaka.

"Not Lost in Translation: Successfully Forging Japanese Pharma and Western Biotech Collaborations" takes place on Tuesday June 17, 2008 from 8:15 - 9:45 AM as part of the 2008 BIO International Convention at San Diego Convention Center. In addition to Mr. Brown, Mr. Pino Modica, Managing Partner of Plexus Ventures will be in attendance throughout the BIO Convention. To inquire about meeting availability, please e-mail mas[.]plexusventures.com.

About Plexus Ventures
Plexus Ventures (plexusventures.com), founded in 1990, provides strategic advice, business development and alliance management services to clients in the pharmaceutical, biotechnology and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in Frankfurt, Indianapolis, London, Los Angeles, Milan, Philadelphia, Tokyo and Warsaw, Plexus Ventures possesses the capabilities to effectively serve clients in the United States, Europe and Asia. Plexus Ventures is both well-known and well respected by leading research-based pharmaceutical companies worldwide.